Study to Assess Effect of Next-Generation Propellant MDI on Mucociliary Clearance Vs. HFA Propellant MDI in Healthy Participants

Clinical trial NCT05755932 · COMPLETED

Trial details

NCT number: NCT05755932
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mucociliary Clearance

Start date: 2023-06-14
Primary completion: 2024-07-22
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.